Literature DB >> 16781671

Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.

David Singer1, Jörg Lehmann, Katja Hanisch, Wolfgang Härtig, Ralf Hoffmann.   

Abstract

Neurofibrillary tangles, which represent a major pathological hallmark in Alzheimer's disease (AD), are deposits of the hyperphosphorylated microtubule-associated tau protein (PHF-tau). However, a link between the phosphorylation pattern and the cause or the progress of AD is still missing. The work reported here focused on PHF-tau specific local phosphorylation patterns at Thr212/Ser214 and Thr231/Ser235 using monoclonal antibodies (mAb) generated against correspondingly modified peptides. The binding motifs of the obtained six mAbs were characterized with non-, mono-, and double-phosphorylated peptides as well as terminally shortened sequences. Five mAbs stained neurofibrillary tangles, neuritic plaques, and neuropil threads from autoptic brains of AD cases. Four mAbs recognized PHF-tau without significant cross-reactivity towards normal human tau, bovine tau, and dephosphorylated PHF-tau in ELISA and Western blot analysis. Thus, double phosphorylation is sufficient to distinguish PHF-tau from all other tau versions and there is no need to postulate any PHF-tau specific conformation for this region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781671     DOI: 10.1016/j.bbrc.2006.05.201

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Ion mobility separation of isomeric phosphopeptides from a protein with variant modification of adjacent residues.

Authors:  Alexandre A Shvartsburg; David Singer; Richard D Smith; Ralf Hoffmann
Journal:  Anal Chem       Date:  2011-06-13       Impact factor: 6.986

2.  Improvement of an antibody-enzyme coupling yield by enzyme surface supercharging.

Authors:  Agneta A Prasse; Thomas Zauner; Karin Büttner; Ralf Hoffmann; Thole Zuchner
Journal:  BMC Biotechnol       Date:  2014-10-18       Impact factor: 2.563

3.  Minibactenecins ChBac7.Nα and ChBac7. Nβ - Antimicrobial Peptides from Leukocytes of the Goat Capra hircus.

Authors:  O V Shamova; D S Orlov; M S Zharkova; S V Balandin; E V Yamschikova; D Knappe; R Hoffmann; V N Kokryakov; T V Ovchinnikova
Journal:  Acta Naturae       Date:  2016 Jul-Sep       Impact factor: 1.845

4.  Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.

Authors:  Jessica E Chukwu; Jan T Pedersen; Lars Ø Pedersen; Christiane Volbracht; Einar M Sigurdsson; Xiang-Peng Kong
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

5.  Structural characterization by NMR of a double phosphorylated chimeric peptide vaccine for treatment of Alzheimer's disease.

Authors:  Karla Ramírez-Gualito; Monique Richter; Manolis Matzapetakis; David Singer; Stefan Berger
Journal:  Molecules       Date:  2013-04-26       Impact factor: 4.411

6.  Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation.

Authors:  Monique Richter; Agneta Mewes; Manuela Fritsch; Ute Krügel; Ralf Hoffmann; David Singer
Journal:  Vaccines (Basel)       Date:  2014-07-29

7.  P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.

Authors:  Juan Lantero-Rodriguez; Anniina Snellman; Andrea L Benedet; Marta Milà-Alomà; Elena Camporesi; Laia Montoliu-Gaya; Nicholas J Ashton; Agathe Vrillon; Thomas K Karikari; Juan Domingo Gispert; Gemma Salvadó; Mahnaz Shekari; Christina E Toomey; Tammaryn L Lashley; Henrik Zetterberg; Marc Suárez-Calvet; Gunnar Brinkmalm; Pedro Rosa Neto; Kaj Blennow
Journal:  EMBO Mol Med       Date:  2021-11-02       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.